1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge.
(
- Contribution to journal › Article
- 2008
-
Mark
Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-I variants emerging during AIDS progression
(
- Contribution to journal › Article
-
Mark
Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
(
- Contribution to journal › Article
- 2007
-
Mark
Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS
(
- Contribution to journal › Article